JENNIFER GILLIS: Open Payments
NPI 1407195688 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 32 payments from 11 companies in 2025. Trend: 2023 $457 · 2024 $700 · 2025 $650
Food & beverage: $650
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 4 | $148 |
| AstraZeneca Pharmaceuticals LP | 6 | $91 |
| PFIZER INC. | 4 | $82 |
| Lilly USA, LLC | 4 | $72 |
| Novo Nordisk Inc | 4 | $63 |
| ABBVIE INC. | 3 | $53 |
| Zimmer Biomet Holdings, Inc. | 1 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Abbott Laboratories | 1 | $25 |
Products named: Dexcom G6 Transmitter, JARDIANCE, NURTEC ODT, AIRSUPRA, ROSA, QULIPTA, Wegovy, Ozempic.
Industry payments across SC — which companies pay providers there.
